Goldman Sachs Raises Calumet Price Target to $24 from $20, Maintains Buy Rating.

viernes, 30 de enero de 2026, 12:46 pm ET1 min de lectura
CLMT--

Goldman Sachs Raises Calumet Price Target to $24 from $20, Maintains Buy Rating.

Goldman Sachs Raises Calumet Price Target to $24 from $20, Maintains Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios